176 related articles for article (PubMed ID: 36450739)
1. Risk of malignancy in patients with psoriasis according to treatment modalities in Korea: a nationwide cohort study.
Hong JY; Ahn J; Won S; Kim SM; Cho YA; Kim CY; Sung JY; Yu DA; Lee YW; Choe YB
Sci Rep; 2022 Nov; 12(1):20690. PubMed ID: 36450739
[TBL] [Abstract][Full Text] [Related]
2. Serious infections and tuberculosis in psoriasis patients receiving systemic therapy in Korea: a nationwide population-based cohort study.
Cho YA; Ahn J; Hong JY; Won S; Kim SM; Sung JY; Kim CY; Yu DA; Lee YW; Choe YB
Eur J Dermatol; 2023 Jun; 33(3):287-295. PubMed ID: 37594337
[TBL] [Abstract][Full Text] [Related]
3. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.
Asgari MM; Ray GT; Geier JL; Quesenberry CP
J Am Acad Dermatol; 2017 Apr; 76(4):632-638. PubMed ID: 28162854
[TBL] [Abstract][Full Text] [Related]
4. The potential impact of systemic anti-inflammatory therapies in psoriasis on major adverse cardiovascular events: a Korean nationwide cohort study.
Hong JR; Jeong H; Kim H; Yang HS; Hong JY; Kim SM; Cho YA; Lee YW; Choe YB; Ahn KJ
Sci Rep; 2021 Apr; 11(1):8588. PubMed ID: 33883587
[TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy in patients with psoriasis: a 15-year nationwide population-based prospective cohort study in Korea.
Lee JW; Jung KJ; Kim TG; Lee M; Oh J; Jee SH; Lee MG
J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2296-2304. PubMed ID: 31287593
[TBL] [Abstract][Full Text] [Related]
6. Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09.
Kimball AB; Schenfeld J; Accortt NA; Anthony MS; Rothman KJ; Pariser D
Br J Dermatol; 2014 Feb; 170(2):366-73. PubMed ID: 24251402
[TBL] [Abstract][Full Text] [Related]
7. The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network.
Chiesa Fuxench ZC; Shin DB; Ogdie Beatty A; Gelfand JM
JAMA Dermatol; 2016 Mar; 152(3):282-90. PubMed ID: 26676102
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of suicidality in patients with psoriasis: A Nationwide cohort study in Korea.
Kim SM; Ahn J; Cho YA; Sung JY; Kim CY; Yu DA; Lee YW; Won S; Choe YB
J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):75-84. PubMed ID: 36028994
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk in 892 089 patients with psoriasis in Korea: A nationwide population-based cohort study.
Lee JH; Kim HJ; Han KD; Kim HN; Park YM; Lee JY; Park YG; Lee YB
J Dermatol; 2019 Feb; 46(2):95-102. PubMed ID: 30443930
[TBL] [Abstract][Full Text] [Related]
10. Increased dental comorbidities in patients with psoriasis: a nationwide population-based cohort study in Korea.
Kwak EJ; Choi YJ; Kim HN; Kim KE; Jeon J; Baek YS
Clin Exp Dermatol; 2023 Nov; 48(12):1347-1353. PubMed ID: 37624999
[TBL] [Abstract][Full Text] [Related]
11. Skin cancer in patients with psoriasis.
Egeberg A; Thyssen JP; Gislason GH; Skov L
J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1349-53. PubMed ID: 26932589
[TBL] [Abstract][Full Text] [Related]
12. Risk of serious infection and infection mortality in patients with psoriasis: A nationwide cohort study using the Taiwan National Health Insurance claims database.
Chen TC; Wang TC; Yiu ZZN; Lee MS; Chen LC; Chan KA; Griffiths CEM; Ashcroft DM;
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):136-144. PubMed ID: 37611288
[TBL] [Abstract][Full Text] [Related]
13. Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States.
Kimball AB; Schenfeld J; Accortt NA; Anthony MS; Rothman KJ; Pariser D
Br J Dermatol; 2015 Nov; 173(5):1183-90. PubMed ID: 26265015
[TBL] [Abstract][Full Text] [Related]
14. Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials.
Blauvelt A; Lebwohl M; Langley RG; Rowland K; Yang YW; Chan D; Miller M; You Y; Yu J; Thaҫi D; Foley P; Papp KA
J Am Acad Dermatol; 2023 Aug; 89(2):274-282. PubMed ID: 37019386
[TBL] [Abstract][Full Text] [Related]
15. Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies.
Naldi L
Clin Dermatol; 2010; 28(1):88-92. PubMed ID: 20082957
[TBL] [Abstract][Full Text] [Related]
16. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS
Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609
[TBL] [Abstract][Full Text] [Related]
17. Impact of biologic agents on body weight and obesity-related disorders in patients with psoriasis: A nationwide population-based cohort study.
Kim H; Hong JY; Cheong S; Kang JH
Obes Res Clin Pract; 2023; 17(3):210-217. PubMed ID: 37211465
[TBL] [Abstract][Full Text] [Related]
18. The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study.
Lee MS; Lin RY; Chang YT; Lai MS
Int J Dermatol; 2012 Dec; 51(12):1454-60. PubMed ID: 23171012
[TBL] [Abstract][Full Text] [Related]
19. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.
Paul CF; Ho VC; McGeown C; Christophers E; Schmidtmann B; Guillaume JC; Lamarque V; Dubertret L
J Invest Dermatol; 2003 Feb; 120(2):211-6. PubMed ID: 12542524
[TBL] [Abstract][Full Text] [Related]
20. Serious infections among a large cohort of subjects with systemically treated psoriasis.
Dobry AS; Quesenberry CP; Ray GT; Geier JL; Asgari MM
J Am Acad Dermatol; 2017 Nov; 77(5):838-844. PubMed ID: 28917384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
